Articles with "intracranial activity" as a keyword



Abstract 4022: Preclinical intracranial activity of NVL-655 in an alectinib-resistant patient-derived model harboring EML4-ALK fusion with G1202R mutation

Sign Up to like & get
recommendations!
Published in 2023 at "Cancer Research"

DOI: 10.1158/1538-7445.am2023-4022

Abstract: Introduction: NVL-655 is a brain-penetrant, ALK-selective tyrosine kinase inhibitor (TKI) designed to maintain activity against ALK and ALK mutations that confer resistance to currently approved therapies, and to avoid neurological adverse events and dose-limiting toxicities… read more here.

Keywords: intracranial activity; nvl 655; eml4 alk; alk ... See more keywords
Photo by robbie36 from unsplash

Intracranial activity of tepotinib in patients (pts) with MET exon 14 (METex14) skipping NSCLC enrolled in VISION.

Sign Up to like & get
recommendations!
Published in 2021 at "Journal of Clinical Oncology"

DOI: 10.1200/jco.2021.39.15_suppl.9084

Abstract: 9084 Background: Brain metastases (BMs) are reported in 20–40% of pts with METex14 skipping NSCLC and present a high unmet need with poor prognosis. Tepotinib is a highly selective MET inhibitor that has demonstrated intracranial… read more here.

Keywords: tepotinib; skipping nsclc; intracranial activity; activity ... See more keywords